Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T17:20:58.330Z Has data issue: false hasContentIssue false
  • English
  • Français

Cancer and Depression: Cancer Presenting with Depressive Illness: An Autoimmune Disease?

Published online by Cambridge University Press:  29 January 2018

J. H. Brown  and
F. Paraskevas
J. H. Brown
Affiliation:
Department of Psychiatry
F. Paraskevas
Affiliation:
Department of Psychiatry
Get access Rights & Permissions [Opens in a new window]

Summary

It is proposed that some cases of depressive illness in cancer patients may be caused by immunological interference with the activity of serotonin, one of the neurotransmitters thought to be implicated in depression. This interference could be mediated in two ways. Antibody induced against a protein released from cancer cells could, on the basis of cross-reactivity with CNS tissue, bind to receptors for serotonin and block them. Such primary antibodies could stimulate the production of anti-idiotypic antibodies, which would act as an alternative receptor for serotonin and reduce its synaptic availability.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 141 , Issue 3 , September 1982 , pp. 227 - 232
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Baird, L. G., Tachovsky, T. G., Sandberg-Wollheim, M., Koprowski, H. & Nisonoff, A. (1980) Identification of a unique idiotype in cerebrospinal fluid and serum of a patient with multiple sclerosis. Journal of Immunology, 124, 2324–48.Google Scholar
Black, S. J., Hammerling, G. J., Berek, C., Rajewsky, K. & Eichman, K. (1976) Idiotypic analysis of lymphocytes in vitro—I. Specificity and heterogeneity of B and T lymphocytes reactive with anti-idiotypic antibody. Journal of Experimental Medicine, 143, 846–60.Google Scholar
Bornstein, M. B. & Crain, S. M. (1965) Functional studies of cultured brain tissues as related to demyelinative disorders. Science, 148, 1242–4.Google Scholar
Brain, W. R. (1963) The neurological complications of neoplasms. Lancet, viii, 179–84.Google Scholar
Carlsson, A., Roseagren, E., Bertler, A. & Nillsson, J. (1957) Effect of reserpine on the metabolism of catecholamines. In Psychotropic Drugs, (eds. Garattini, S. and Ghetti, V.). Amsterdam: Elsevier.Google Scholar
Carnegie, P. R. (1971) Properties, structure and possible neuroreceptor role of the encephalitogenic protein of human brain. Nature, 229, 25–8.CrossRefGoogle ScholarPubMed
Caspary, E. A. & Field, E. J. (1971) Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? British Medical Journal, ii, 613–17.Google Scholar
Cazzullo, C. L., Brazzelli, C. A. & Giodano, P. L. (1969) 5-hydroxytryptamine content in rabbit brains in experimental allergic encephalomyelitis. In Pathogenesis and Etiology of Demyelinating Disease, Supplement to the International Archives of Allergy, 36, 234–41.Google Scholar
Coates, A. S. & Carnegie, P. R. (1975) Immunological cross-reactivity between basic proteins of myelin and cancer: I. Lymphocyte transformation studies in immunized guinea pigs. Clinical and Experimental Immunology (Oxford), 22, 16–21.Google Scholar
Evans, N. J. R., Baldwin, J. A. & Gath, D. (1974) The incidence of cancer among patients with affective disorders. British Journal of Psychiatry, 124, 518–25.Google Scholar
Field, E. J., Caspary, E. A. & Carnegie, P. R. (1971) Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds. Nature, 233, 284–6.CrossRefGoogle ScholarPubMed
Fras, I., Litin, E. M. & Pearson, J. S. (1967) Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other abdominal neoplasma. American Journal of Psychiatry, 123, 1553–62.Google Scholar
Fuxe, K., Hökfelt, T. & Ungerstedt, V. (1969) Distribution of monoamines in the mammalian central nervous system by histochemical studies. In Metabolism of Amines in the Brain, (ed. Hooper, G.). London: Macmillan.Google Scholar
Goodwin, F. K. & Potter, W. Z. (1978) The biology of affective illness; amine neurotransmitters and drug response. In Depression: Biology, Psychodynamics and Treatment, (eds. Cole, J. O., Schatzberg, A. F. and Frazier, S. H.). New York and London: Plenum Press.Google Scholar
Goldstone, A. H., Kerr, K. & Irvine, W. J. (1973) The Macrophage Electrophoretic Migration Test in cancer. Clinical and Experimental Immunology, 14, 469–72.Google ScholarPubMed
Green, A. R. & Costain, D. W. (1979) The biochemistry of depression. In Psychopharmacology of Affective Disorders, (eds. Paykel, E. S. and Coppen, A.). Oxford University Press.Google Scholar
Henson, R. A. (1970) Non-metastatic neurological manifestations of malignant disease. In Modern Trends in Neurology, (ed. Williams, D.). London: Butterworths.Google Scholar
Hoffman, P. M., Gaston, D. D. & Spitler, L. E. (1973) Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein and synthetic encephalitogenic peptide. Clinical Immunology and Immunopathology, 1, 364–71.Google Scholar
Kerr, T. A., Schapira, K. & Roth, M. (1969) The relationship between premature death and affective disorders. British Journal of Psychiatry, 115, 1277–82.Google Scholar
Kline, N. S. (1958) Clinical experience with iproniazid (marsilid). Journal of Clinical and Experimental Psychopathology, Supplement 1, 19, 72–9.Google Scholar
Lennon, Y. A. & Carnegie, P. R. (1971) Immunopharmacological disease: A break in tolerance to receptor sites. Lancet, i, 630–3.Google Scholar
Lennon, V., Feldman, M. & Crawford, M. (1972) The detection of auto-antibody forming cells, II. Cells in the lymph nodes and central nervous system containing antibody to myelin basic protein. International Archives of Allergy, 43, 749–58.Google Scholar
Lycke, E. & Roos, B. E. (1973) Brain monoamines in guinea pigs with experimental allergic encephalitis. International Archives of Allergy, 45, 341–51.CrossRefGoogle ScholarPubMed
Maas, J. W. (1975) Biogenic amines and depression. Archives of General Psychiatry, 32, 1357–61.Google Scholar
MarChBanks, R. M. (1966) Serotonin binding to nerve ending particles and other preparations from rat brain. Journal of Neurochemistry, 13, 1481–93.Google Scholar
Murphy, M. R. (1958) Response of oligodendrocytes to serotonin. In Biology of Neuroglia, (ed. Windle, W. R.). Springfield, Illinois: Thomas.Google Scholar
Niemi, T. & Jääskeläinen, (1978) Cancer morbidity in depressive persons. Journal of Psychosomatic Research, 22, 117–20.Google Scholar
Paterson, P. Y. (1960) Transfer of allergic encephalomyelitis in rats by means of lymph node cells. Journal of Experimental Medicine, 111, 119–36.Google Scholar
Paterson, P. Y. & Harwin, S. M. (1963) Suppression of allergic encephalomyelitis in rats by means of anti-brain antiserum. Journal of Experimental Medicine, 117, 755–74.Google Scholar
Preece, A. W. & Light, P. A. (1974) The Macrophage Electrophoretic Mobility (MEM) Test for malignant disease. Clinical and Experimental Immunology (Oxford), 18, 543–52.Google Scholar
Pritchard, J. A. V., Moore, J. L., Sutherland, W. H. & Joslin, C. A. F. (1972) Evaluation and development of the Macrophage Electrophoretic Mobility (MEM) Test for malignant disease. British Journal of Cancer, 27, 1–9.Google Scholar
Raine, C. S. & Bornstein, M. B. (1970) Experimental allergic encephalomyelitis: an ultrastructural study of experimental demyelination in vitro. Journal of Neuropathology and Experimental Neurology, 29, 117–91.Google Scholar
Raine, C. S., Hummelgard, A., Swanson, E. & Bornstein, M. B. (1973) Multiple sclerosis: Serum-induced demyelination in vitro. A light and electron microscope study. Journal of Neurology and Sciences, 20, 127–48.Google Scholar
Rauch, H. C. & Frick, O. L. (1967) Suppression effect of anti-allergic mediators on experimental encephalomyelitis. Proceedings of the Society of Experimental Biology and Medicine, (NY), 124, 667.Google Scholar
Sege, K. & Peterson, P. A. (1978) Use of anti-idiotypic antibodies as cell surface receptor probes. Proceedings of the National Academy of Sciences, 75, 2443–7.Google Scholar
Shore, P. A., Silver, S. L. & Brodie, B. B. (1955) Interaction of reserpine, serotonin and lysergic acid diethylamide in brain. Science, 122, 284–5.Google Scholar
Simon, J. & Simon, O. (1975) Effect of passive transfer of anti-brain antibodies to a normal recipient. Experimental Neurology, 47, 523–34.Google Scholar
Smythies, J. R., Bennington, F. & Morin, R. D. (1970) Specification of a possible serotonin receptor site in the brain. Neurosciences Research Program Bulletin, 8, 117–22.Google Scholar
Sourkes, T. L. (1977) Biochemistry of mental depressions. Canadian Psychiatric Association Journal, 22, 467–81.Google Scholar
van Praag, H. M. (1980) Amine hypothesis of affective disorders. In Handbook of Psychopharmacology, Volume 13 (eds. Iverson, L. L., Iverson, S. D. and Snyder, S. H.). New York and London: Plenum Press.Google Scholar
Watts, C. A. H. (1966) Depressive Disorders in the Community, Bristol: Wright.Google Scholar
Weinstock, M., Shoham-Moshonov, S., Teitelbaum, D. & Arnon, R. (1977) Inactivation of neurogenic 5-hydroxytryptamine receptors in guinea pigs with experimental allergic encephalomyelitis (EAE) induced paralysis. Brain Research, 125, 191–5.Google Scholar
Whitlock, F. A. (1976) Suicide, cancer and depression. British Journal of Psychiatry, 132, 269–74.Google Scholar
Whitlock, F. A. & Siskind, M. (1979) Depression and cancer: a follow-up study. Psychological Medicine, 9, 747–52.Google Scholar
Wilkinson, P. C. & Zerowski, J. (1965) Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain, 88, 529–40.Google Scholar
Woolley, D. W. & Shaw, E. (1954) Some neurophysical aspects of serotonin. British Medical Journal, ii, 122–6.Google Scholar
Zeller, E. A., Barsky, J. & Berman, E. R. (1955) Inhibition of monoamine oxidase by 1-isonicotinyl-2-isopropylhydrazine. Journal of Biological Chemistry, 214, 267–74.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.